Notably, RBP4 links adiposity and insulin resistance to cancer biology, with its role being more pronounced in individuals with lower BMI due to adipose tissue dysfunction in obesity [19,21,23,24,25]. Here, RBP4 is linked to obesity due to melanocortin 4 receptor deficiency.